Metformin Sensitizes HR+/HER2- Breast Cancer Cells to CDK4/6 Inhibitor via Suppressing of PI3K/AKT/mTOR Signaling Pathway
Drug Design, Development and Therapy · 2026-07 · Volume 20 · 1-18
DOI: 10.2147/dddt.s544583 ↗Kurz gefasst
Fachartikel in der Zeitschrift Drug Design, Development and Therapy, 2026-07. Verfasst von Lin Zhu und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, People's Republic of China. Hauptthemen laut MEDLINE: Metformin, Cyclin-Dependent Kinase 4, Cyclin-Dependent Kinase 6, Breast Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacy, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, People's Republic of China.
- Department of Obstetrics and Gynecology, Zhengzhou Central Hospital Affiliated to Zhengzhou University, Zhengzhou, Henan, People's Republic of China.
- Department of Orthopedic Surgery, Sarcoma Biology Laboratory, Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, FL, USA.
ORCID-Profile: Yubing Zhou
Zitieren
APA
Zhu, L., Yang, J., Li, F., Wang, D., Zhang, W., Zhang, J., Duan, Z., Hu, Y., & Zhou, Y. (2026). Metformin Sensitizes HR+/HER2- Breast Cancer Cells to CDK4/6 Inhibitor via Suppressing of PI3K/AKT/mTOR Signaling Pathway. Drug Design, Development and Therapy, Volume 20, 1-18. https://doi.org/10.2147/dddt.s544583
Vancouver
Zhu L, Yang J, Li F, Wang D, Zhang W, Zhang J, et al. Metformin Sensitizes HR+/HER2- Breast Cancer Cells to CDK4/6 Inhibitor via Suppressing of PI3K/AKT/mTOR Signaling Pathway. Drug Design, Development and Therapy. 2026;Volume 20:1-18. doi:10.2147/dddt.s544583
BibTeX
@article{Zhu2026,
author = {Zhu, Lin and Yang, Jiawen and Li, Fengmei and Wang, Dandan and Zhang, Wenda and Zhang, Jingmin and Duan, Zhenfeng and Hu, Youhong and Zhou, Yubing},
title = {Metformin Sensitizes HR+/HER2- Breast Cancer Cells to CDK4/6 Inhibitor via Suppressing of PI3K/AKT/mTOR Signaling Pathway},
journal = {Drug Design, Development and Therapy},
year = {2026},
volume = {Volume 20},
pages = {1--18},
doi = {10.2147/dddt.s544583}
}
EUVIMED